Unlike hGH, Sermorelin affects a more primary source
of age-failure in the GH neuroendocrine axis, has more physiological
activity and better safety profile.
Sermorelin is a biological active analog of growth
hormone releasing hormone (GHRH) that is produced by the human brain to
stimulate production and release of growth hormone by the pituitary
gland. During youth, ample amounts of GHRH are produced so that the
pituitary is able to provide the body with sufficient growth hormone to
sustain health, vitality and otherwise normal aspects of form and
function. However, during aging, GHRH declines causing reduced
production and secretion of pituitary hGH and thereby increasing the
sequelae of growth hormone insufficiency that erodes health, vigor and
vitality during later life.
Thus, Sermorelin should be considered a valuable
alternative to hGH by anti-aging practitioners seeking to provide the
best and most contemporary interventions in aging for their patients.
